Mirion price target raised to $20 from $18 at Citi

Citi raised the firm’s price target on Mirion (MIR) to $20 from $18 and keeps a Buy rating on the share following the investor day. The company highlighted several growth and margin expansion drivers that should be supportive of its introduced 2025 guidance and targets through 2028, the analyst tells investors in a research note. The firm says the company’s trends seem supportive of good growth potential heading into 2025. Favorable secular trends and a strong market position across both nuclear, safety and medical should “remain relatively sustainable tailwinds,” contends Citi.